West Pharmaceutical Services, Inc. (WST) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging componen...
West Pharmaceutical Services, Inc. (WST) currently trades at a P/E ratio of 46.06 (historical range: 29.37–51.32, median: 40.05), placing it at the 78th percentile — above its historical average, P/S ratio of 7.76 (range: 4.80–8.91, 74th percentile — above its historical average), EV/EBITDA of 139.35 (range: 25.25–153.46, 82th percentile).
West Pharmaceutical Services, Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 46.06 | 29.37 | 40.05 | 51.32 | 78th | above its historical average |
| P/S Ratio | 7.76 | 4.80 | 6.55 | 8.91 | 74th | above its historical average |
| EV/EBITDA | 139.35 | 25.25 | 59.95 | 153.46 | 82th | expensive relative to its history |
| FCF Yield | 0.00 | 0.00 | 0.01 | 0.03 | 8th | expensive relative to its history |